Hide Board Information

Show Board Information

Washington Mutual De WAMKQ

Board Mod: Add me as mod

Asst Mods:

Last Post: 01/17/2012 12:59:24 AM

Board Marks: 0

Posts Today: 0

Board Views Today: 1

Washington Mutual De (OTCMRKTS: WAMKQ) Stock Message Board

1. WAMKQ Company Profile

    

2. WAMKQ Time & Sales

    

3. WAMKQ Recent News

    

4. WAMKQ Filings

    

5. WAMKQ Financials

    

6. WAMKQ Buy Rating

Create New Post View All Posts Board Mark Banned

Post

Subject

Author

Posted On

Be the first to post on Washington Mutual De WAMKQ

Recent Articles

• Ascentage Pharma's Innovative Treatment: A New Hope in Oncology
• Harnessing Xi Jinping's Economic Thought for China's Growth
• Investing in Next-Gen Mpox Detection Testing: GHIT Fund's Role
• Innovent Biologics' Groundbreaking First-in-Human Study Unveiled
• Hydron Energy Innovations in Carbon-Negative Xenon Production
• Skyline Digital Marketing's Unique Method for Business Growth
• Reviving Heritage: The Digital Transformation of Dunhuang Caves
• CARsgen's Innovative CT0596 Therapy Shows Promise in Trials
• HUTCHMED Expands Coverage of Innovative Drugs in China
• ChemLex Secures $45M to Revolutionize Drug Discovery Tech
• ElevenLabs Innovates Hollywood: AI Voice Cloning Revolution
• How Avantor, Inc. Investors Can Take Action on Losses
• Mitsubishi Electric Joins Linux Foundation As Gold Member
• Respiree's AI Software Gains HSA Approval for Patient Monitoring
• ChemLex Secures $45 Million to Revolutionize Drug Discovery
• ALLUONE Introduces Innovative Smart Garden for Urban Homes
• Exploring Open Source in Japan: Opportunities and Challenges
• ChemLex Secures $45 Million Overhaul for Drug Discovery Lab
• CarMax, Inc. Investors Urged to Join Class Action Lawsuit
• Immix Biopharma Achieves Landmark Phase 2 Success with NXC-201
• Immix Biopharma's Strategic $100 Million Stock Offering Explained
• Structure Therapeutics Unveils Upcoming Data from ACCESS Program
• Crypto’s ETF Wave and The New Investment Gateway Beyond Bitcoin
• Matthews International Strategically Navigates Market Challenges
• Positive Results from SELLAS Life Sciences' SLS009 Phase 2 Study
• BeOne Medicines Celebrates Progress of Sonrotoclax in CLL Treatment
• Investors Rally: Join Class Action Against James Hardie Industries
• Transforming Crypto Trading: Anchorage Digital's Partnership
• ImCheck Showcases Promising Efficacy of ICT01 in AML Trials
• Lime & Lemon Apex: A Game-Changer in Collective Dining
• Exciting Developments in Chibougamau Copper-Gold Project
• Analyzing China's Military Advancements and Global Impact
• Rosen Law Firm Investigates Potential Claims for Aglion Health Investors
• Lyell Immunopharma Unlocks Promising Results for Ronde-Cel
• Lynozyfic™ Shows Potential as Frontline Treatment for Myeloma
• Promising Results in Lyell Immunopharma's Ronde-Cel Trial
• Eli Lilly's Jaypirca Achieves Key Milestone in Latest Study
• How Leading Tech Companies Maintain Dominance with Automation
• Wave Life Sciences Set to Reveal Key Trial Data for Obesity
• Embracing Work-Life Balance: A Shift in Employee Priorities
• Power of Attorney Attestation Dubai: Legal Use Cases and Process Guide
• Transforming Investor Mindsets: The Power of Just $1
• Hidden Project Risks That Can Ruin Your Timeline and How To Prevent Them
• Apple Facing Leadership Changes Amid AI Development Concerns
• Elderly Victim's Heartbreaking Loss in Crypto ATM Scam
• Replicor's Innovative Approach to Treating HBV and HDV Infections
• Sundar Pichai on AI Revolutionizing Decisions from Finance to Health
• Prologis to Redeem 3.00% Notes Ahead of 2026 Maturity
• Prologis to Redeem Outstanding Bonds Ahead of Schedule
• Exploring the Sinister Connections of Russian Cyber Attacks